welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk
Quest Diagnostics launches three new test panels under its Quest Vantage brand. The lab-developed panels employ next-generation sequencing and a proprietary bioinformatics platform to identify genetic mutations associated with inherited risk of 15 cancers. According to the company, ~170K diagnoses are made in the U.S. each year of cancers that result from inherited genetic mutations. The tests only include genes that meet certain criteria such as a 2x increase in cancer risk, an association with a disease syndrome where cancer may occur and guideline support for genetic counseling. Quest will showcase the new panels at ASCO in Chicago.
expertly curated content related to this topic
- The Johns Hopkins Guide for Patients and Families: Familial Adenomatous PolyposisINTRODUCTION This booklet is written fo...
- Attitudes Toward Genetic Testing in Childhood and Reproductive Decision-Making for Familial Adenomatous PolyposisChildhood DNA testing, prenatal diagnosi...
- Small-Bowel Capsule Endoscopy and Device-Assisted Enteroscopy for Diagnosis and Treatment of Small Bowel Disorders: ...This Guideline is an official statement ...
- Diagnostic Values of Dual Focus Narrow Band Imaging and Probe-Based Confocal Laser Endomicroscopy in FAP-Related Duo...BACKGROUND AND STUDY AIMS : Familial ade...
- Lynch Syndrome and MYH-Associated Polyposis: Review and Testing StrategyIndividuals with Lynch syndrome have an ...
- Gross Appearance of a Villous Adenomahttp://library.med.utah.edu/WebPath/jpeg...
- A Proposed Staging System and Stage-Specific Interventions for Familial Adenomatous PolyposisBACKGROUND : It is not possible to accur...
English
Portuguese